Shukra Pharmaceuticals Ltd — Insider Trading, 23-06-2026: Insider Trading / SAST

Shukra Pharmaceuticals has closed its trading window for key personnel, including promoters, directors, and their immediate relatives, starting July 1, 2026. This measure is effective until 48 hours after the company declares its financial results for the quarter ended June 30, 2026. This is a standard practice to prevent insider trading before crucial financial information is made public. Affected individuals are advised against trading in company securities during this period. The company will announce the date for its Board Meeting to approve these quarterly financial results in due course.